vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and XPEL, Inc. (XPEL). Click either name above to swap in a different company.

XPEL, Inc. is the larger business by last-quarter revenue ($122.3M vs $121.8M, roughly 1.0× Core Laboratories Inc.). XPEL, Inc. runs the higher net margin — 11.0% vs 4.2%, a 6.8% gap on every dollar of revenue. On growth, XPEL, Inc. posted the faster year-over-year revenue change (13.7% vs -1.4%). XPEL, Inc. produced more free cash flow last quarter ($1.6M vs $517.0K). Over the past eight quarters, XPEL, Inc.'s revenue compounded faster (16.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

XPEL, Inc. is a global provider of high-performance surface protection solutions primarily for automotive use. Core offerings include paint protection films, window tints, and ceramic coatings, serving vehicle owners, dealerships, and professional installers across North America, Europe, and Asia Pacific.

CLB vs XPEL — Head-to-Head

Bigger by revenue
XPEL
XPEL
1.0× larger
XPEL
$122.3M
$121.8M
CLB
Growing faster (revenue YoY)
XPEL
XPEL
+15.2% gap
XPEL
13.7%
-1.4%
CLB
Higher net margin
XPEL
XPEL
6.8% more per $
XPEL
11.0%
4.2%
CLB
More free cash flow
XPEL
XPEL
$1.1M more FCF
XPEL
$1.6M
$517.0K
CLB
Faster 2-yr revenue CAGR
XPEL
XPEL
Annualised
XPEL
16.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
XPEL
XPEL
Revenue
$121.8M
$122.3M
Net Profit
$5.1M
$13.4M
Gross Margin
41.9%
Operating Margin
1.5%
12.7%
Net Margin
4.2%
11.0%
Revenue YoY
-1.4%
13.7%
Net Profit YoY
50.7%
EPS (diluted)
$0.11
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
XPEL
XPEL
Q1 26
$121.8M
Q4 25
$138.3M
$122.3M
Q3 25
$134.5M
$125.4M
Q2 25
$130.2M
$124.7M
Q1 25
$123.6M
$103.8M
Q4 24
$129.2M
$107.5M
Q3 24
$134.4M
$112.9M
Q2 24
$130.6M
$109.9M
Net Profit
CLB
CLB
XPEL
XPEL
Q1 26
$5.1M
Q4 25
$4.9M
$13.4M
Q3 25
$14.2M
$12.9M
Q2 25
$10.6M
$16.3M
Q1 25
$-154.0K
$8.6M
Q4 24
$7.4M
$8.9M
Q3 24
$11.7M
$14.9M
Q2 24
$9.0M
$15.0M
Gross Margin
CLB
CLB
XPEL
XPEL
Q1 26
Q4 25
20.8%
41.9%
Q3 25
22.0%
41.8%
Q2 25
20.3%
42.9%
Q1 25
19.5%
42.3%
Q4 24
17.8%
40.6%
Q3 24
20.5%
42.5%
Q2 24
21.2%
43.5%
Operating Margin
CLB
CLB
XPEL
XPEL
Q1 26
1.5%
Q4 25
11.5%
12.7%
Q3 25
15.6%
13.4%
Q2 25
11.7%
15.5%
Q1 25
3.6%
10.7%
Q4 24
11.0%
11.5%
Q3 24
14.7%
16.3%
Q2 24
12.3%
17.5%
Net Margin
CLB
CLB
XPEL
XPEL
Q1 26
4.2%
Q4 25
3.6%
11.0%
Q3 25
10.6%
10.3%
Q2 25
8.2%
13.1%
Q1 25
-0.1%
8.3%
Q4 24
5.7%
8.3%
Q3 24
8.7%
13.2%
Q2 24
6.9%
13.7%
EPS (diluted)
CLB
CLB
XPEL
XPEL
Q1 26
$0.11
Q4 25
$0.11
$0.48
Q3 25
$0.30
$0.47
Q2 25
$0.22
$0.59
Q1 25
$0.00
$0.31
Q4 24
$0.15
$0.33
Q3 24
$0.25
$0.54
Q2 24
$0.19
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
XPEL
XPEL
Cash + ST InvestmentsLiquidity on hand
$22.8M
$50.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$280.3M
Total Assets
$587.7M
$382.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
XPEL
XPEL
Q1 26
$22.8M
Q4 25
$22.7M
$50.9M
Q3 25
$25.6M
$64.5M
Q2 25
$31.2M
$49.6M
Q1 25
$22.1M
$23.5M
Q4 24
$19.2M
$22.1M
Q3 24
$21.5M
$21.0M
Q2 24
$17.7M
$15.0M
Total Debt
CLB
CLB
XPEL
XPEL
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
XPEL
XPEL
Q1 26
$275.1M
Q4 25
$266.0M
$280.3M
Q3 25
$271.3M
$269.3M
Q2 25
$261.3M
$255.7M
Q1 25
$253.4M
$235.5M
Q4 24
$246.6M
$225.5M
Q3 24
$250.7M
$218.7M
Q2 24
$240.3M
$201.9M
Total Assets
CLB
CLB
XPEL
XPEL
Q1 26
$587.7M
Q4 25
$584.0M
$382.5M
Q3 25
$591.4M
$387.7M
Q2 25
$602.1M
$318.1M
Q1 25
$591.5M
$294.8M
Q4 24
$585.1M
$285.6M
Q3 24
$600.5M
$273.0M
Q2 24
$597.8M
$261.8M
Debt / Equity
CLB
CLB
XPEL
XPEL
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
XPEL
XPEL
Operating Cash FlowLast quarter
$4.0M
$2.7M
Free Cash FlowOCF − Capex
$517.0K
$1.6M
FCF MarginFCF / Revenue
0.4%
1.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
0.77×
0.20×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$62.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
XPEL
XPEL
Q1 26
$4.0M
Q4 25
$7.9M
$2.7M
Q3 25
$8.5M
$33.2M
Q2 25
$13.9M
$27.9M
Q1 25
$6.7M
$3.2M
Q4 24
$20.6M
$6.3M
Q3 24
$13.1M
$19.6M
Q2 24
$17.1M
$26.9M
Free Cash Flow
CLB
CLB
XPEL
XPEL
Q1 26
$517.0K
Q4 25
$5.0M
$1.6M
Q3 25
$6.5M
$32.2M
Q2 25
$10.4M
$26.9M
Q1 25
$3.9M
$2.2M
Q4 24
$17.4M
$4.7M
Q3 24
$10.4M
$18.3M
Q2 24
$14.3M
$25.1M
FCF Margin
CLB
CLB
XPEL
XPEL
Q1 26
0.4%
Q4 25
3.6%
1.3%
Q3 25
4.8%
25.6%
Q2 25
8.0%
21.6%
Q1 25
3.1%
2.1%
Q4 24
13.4%
4.4%
Q3 24
7.7%
16.2%
Q2 24
10.9%
22.8%
Capex Intensity
CLB
CLB
XPEL
XPEL
Q1 26
Q4 25
2.1%
0.9%
Q3 25
1.5%
0.8%
Q2 25
2.7%
0.8%
Q1 25
2.3%
1.0%
Q4 24
2.5%
1.5%
Q3 24
2.0%
1.1%
Q2 24
2.2%
1.6%
Cash Conversion
CLB
CLB
XPEL
XPEL
Q1 26
0.77×
Q4 25
1.61×
0.20×
Q3 25
0.60×
2.56×
Q2 25
1.31×
1.71×
Q1 25
0.38×
Q4 24
2.78×
0.71×
Q3 24
1.12×
1.31×
Q2 24
1.90×
1.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

XPEL
XPEL

Products$90.9M74%
Service Revenue Installation Labor$23.8M19%
Service Revenue Cutbank Credits$4.1M3%
Service Revenue Software$2.2M2%

Related Comparisons